A population-based study of cardiovascular disease mortality risk in US cancer patients (2019)

Peer-Reviewed Study · Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, Kelly SP, Zaorsky NG · December 21, 2019

Sturgeon KM et al., 2019-12-21: SEER analysis of 3,234,256 US cancer survivors diagnosed 1973-2012. 11.3% died of cardiovascular disease, and in eight cancer sites CVD mortality exceeded index-cancer mortality in at least one calendar year.

Among 28 cancer types, 1 228 328 patients (38.0%) died from cancer and 365 689 patients (11.3%) died from CVDs.

Abstract (Methods and Results)

Sturgeon KM et al., 2019-12-21: SEER analysis of 3,234,256 US cancer survivors diagnosed 1973-2012. 11.3% died of cardiovascular disease, and in eight cancer sites CVD mortality exceeded index-cancer mortality in at least one calendar year. Comparator: US general population (standardised mortality ratios), adjusted for age, race and sex. Funder/COI not in the abstract. Establishes that very large, decades-long follow-up datasets exist and are published – the opposite of 'virtually nonexistent'. Note for the record: this is all-cancer mortality, not chemotherapy-attributed mortality; treatment data are not in SEER.